Dedicated to revolutionizing neurology care, you aspire to usher in novel, life-changing therapeutics. At Quest Diagnostics, we share your passion and vision. From discovery to diagnostic commercialization, let's collaborate to turn ambitions into achievements.
We can help you design and execute clinical trials, navigate regulatory requirements, and ensure that your medicines are available to patients on day-one.
As a unique global R&D entity supporting preclinical discovery to diagnostic commercialization, our goal is to help you reach your milestones more efficiently. We prioritize seamless transitions, conserving insights, and understanding as you progress through each phase.
Enhance your neurology strategy to resonate more meaningfully with the global community affected by neurological disorders.
We ensure synchronicity between diagnostics and therapeutics from the get-go, optimizing both patient accessibility and your return on investment.
.
When it comes to the commercialization of a new pharmaceutical product, time is of the essence. We support day-one ready lab testing, education, awareness, and support programs to ensure patients can receive the therapy they need without delay.
Rely on Quest for a cohesive, end-to-end service experience. From scientists, customer service, information technology, specimen collection, and transport teams, to quality testing, we combine everything into a single, integrated offering, including:
• Specimen collection centers
• Mobile collection units
• Expert interpretation
With access to over 60 billion lab test results, an expanding range of more than 3,500 assays, and a database encompassing approximately half of the US population, we are poised to provide you with the insights necessary for data-informed decision-making at pivotal development junctures.
Tap into Quest's vast commercialization know-how, bolstered by our versatile team. We present a rich portfolio alongside tailored partnership solutions:
Ensure the diagnostic test is available operationally to complement your therapeutic upon its approval, all facilitated by our wide-range of laboratory networks.
Speed up testing processes with improved pipeline transparency, targeted outreach, and forecasting, all made possible by Quest Diagnostics bioinformatics expertise.
Boost awareness and ease the ordering process for companion or complementary diagnostic tests. This is achieved through both past and future collaborations between healthcare providers and our medical affairs division at Quest.
Enhance patient reach to your therapeutic solution by tailoring strategies to address diagnostic use hurdles, healthcare provider training, and concerns over testing coverage.
Through the Pack Health proven white-label solution, strive for better adherence, an elevated patient experience, and cost-effective care management.
Assess AD risk with a simple, accessible, and affordable blood test.
This test is used to assist in the differential diagnosis of AD and establishes a baseline and monitors over time. Our high-precision assay, using a simple blood sample, is the same type of assay shown to be as effective as traditional standard of care methods, such as cerebrospinal fluid (CSF) testing and amyloid positron emission tomography (PET) scans.
Apolipoprotein E (ApoE), the primary brain apolipoprotein, is a biomarker for AD that can be found in the blood or CSF. The presence of an E4 allele is associated with both increased disease risk and decreased average age of onset compared with E2 or E3 alleles.
Can be ordered alongside other tests in the QUEST AD-Detect portfolio, such as QUEST AD-Detect Amyloid Beta 42/40, for a more robust risk assessment.
.
Contact our pharma solutions experts to design a custom program to accommodate the needs of your study.
Accelerating Alzheimer’s Therapy Innovation: The Power of Blood-Based Biomarkers
Revolutionizing Alzheimer's Disease Clinical Trials Using a Blood-Based Diagnostic Test for Participant Identification
Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services. Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services.
Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.
